Six new indications/molecules were approved by FDA in February 2021 including the following: Melphalan flufenamide in combination with dexamethasone for adult...
Home
What is Alzheimer's disease? Alzheimer's is an irreversible neurodegenerative disease that usually starts slowly and gradually worsens over time. The exact cause of...
In January 2021, the FDA approved the following new indications/Molecules. Combination of nivolumab and cabozantinib as first-line treatment for patients...
What is Amyloidosis? An amyloidosis is a group of serious and rare diseases in which abnormal proteins, known as amyloid...
Calciphylaxis is an uncommon, rare, serious, and fatal disorder that is characterized by: Calcification of the small blood vessels...
Char syndrome is a rare, genetic, multiple congenital anomalies/dysmorphic syndrome characterized by: Triad of patent ductus arteriosus (PDA) Typical facial...
In December 2020, five (5) molecules were approved for the treatment of hematology/oncology disorders. Osimertinib for adjuvant therapy after tumor...
Sickle cell disease is a hereditary problem that causes a type of faulty hemoglobin in red blood cells. Hemoglobin carries...
It seems that the hope of gene therapy for transfusion-dependent β-thalassemia (TDT) is becoming so close. During the 62nd American Society...
In November, three (3) indications/molecules were approved by FDA: Sonalleve MR-HIFU system for the treatment of osteoid osteoma in the...